Vivo Capital Fund VIII L.P. - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vivo Capital Fund VIII L.P.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-04-01
Sale		2024-04-03
8:47 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		420,663$6.6487$2,796,859268,573
(Indirect)		View
2023-12-15
Sale		2023-12-19
6:00 pm		IMPEL PHARMACEUTICALS INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		575,000$0.12892$74,131280,294
(Indirect)		View
2023-11-21
Sale		2023-11-22
6:51 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner		3,400$0.9$3,0601,559,948
(Indirect)		View
2023-11-16
Sale		2023-11-20
9:09 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner		77,843$0.92875$72,2971,561,405
(Indirect)		View
2022-12-23
Purchase		2022-12-23
5:48 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		758,620$7.25$5,499,9956,657,992
(Indirect)		View
2022-09-07
Purchase		2022-09-08
8:00 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		600,000$3.6$2,160,0005,899,372
(Indirect)		View
2022-08-12
Purchase		2022-08-16
8:44 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		2,624,239$2.6599$6,980,2446,799,372
(Indirect)		View
2021-04-27
Purchase		2021-04-29
9:10 pm		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		575,000$15$8,625,000349,674
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2021-04-27
Conversion		2021-04-29
9:10 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		101,456$13.5349,674
(Indirect)		View
2021-04-27
Conversion		2021-04-29
9:10 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		39,725,922$0349,674
(Indirect)		View
2021-04-22
Other		2021-04-26
6:24 pm		N/A
2021-12-31		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		1,359,799$01,359,799
(Indirect)		View

Ownership		2021-04-22
9:30 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		0$02,208,333
(Indirect)		View